Skip to main content
SpringerLink
Log in

Sirtuin 1 (SIRT1) and Oxidative Stress

  • Reference work entry
  • First Online:
Systems Biology of Free Radicals and Antioxidants

Abstract

Sirtuin 1 (SIRT1) is a NAD+-dependent histone/protein deacetylase that regulates a variety of cellular functions such as genome maintenance, longevity, and metabolism. This chapter focuses on the functions of SIRT1 in the context of oxidative stress. SIRT1 stimulates mitochondrial biogenesis, reduces superoxide generation from the respiratory chain, and enhances manganese superoxide dismutase (SOD2) expression in mitochondria, resulting in increased mitochondrial superoxide dismutation. By elevating cellular levels of tetrahydrobiopterin, SIRT1 prevents superoxide production from the uncoupled endothelial nitric oxide synthase. In addition, SIRT1 accelerates the detoxification of reactive oxygen species by upregulating cellular antioxidant enzymes, including SOD1, catalase, glutathione peroxidase 1, and thioredoxin-1. On the other hand, oxidative stress modulates SIRT1 expression and activity. Whereas the upregulation of SIRT1 expression has been reported in several pathological situations, chronic stress conditions are likely to downregulate SIRT1 levels. Furthermore, oxidative stress promotes posttranslational modifications and the degradation of SIRT1 and reduces the cellular concentration of NAD+. Thus, a successful pharmacological approach should not only overcome the pathological downregulation of SIRT1 expression but also improve NAD+ availability and SIRT1 activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 2,999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100:1512–1521

    Article  CAS  PubMed  Google Scholar 

  • Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM (2004) Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24:445–450

    Article  CAS  PubMed  Google Scholar 

  • Bai P, Canto C, Brunyanszki A, Huber A, Szanto M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Menissier-de Murcia J, Schreiber V, Sauve AA, Auwerx J (2011a) PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13:450–460

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011b) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13:461–468

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Beauloye C, Bertrand L, Horman S, Hue L (2011) AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 90:224–233

    Article  CAS  PubMed  Google Scholar 

  • Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M (2009) Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 74:619–624

    Article  CAS  PubMed  Google Scholar 

  • Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280:17187–17195

    Article  CAS  PubMed  Google Scholar 

  • Braidy N, Guillemin G, Grant R (2008) Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease. Neurotox Res 13:173–184

    Article  CAS  PubMed  Google Scholar 

  • Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R (2011) Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One 6:e19194

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011–2015

    Article  CAS  PubMed  Google Scholar 

  • Caito S, Rajendrasozhan S, Cook S, Chung S, Yao H, Friedman AE, Brookes PS, Rahman I (2010) SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 24:3145–3159

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Calabrese EJ, Mattson MP, Calabrese V (2010) Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol 29:980–1015

    Article  CAS  PubMed  Google Scholar 

  • Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056–1060

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11:213–219

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390–392

    Article  CAS  PubMed  Google Scholar 

  • Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297:H13–H20

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dai H, Kustigian L, Carney D, Case A, Considine T, Hubbard BP, Perni RB, Riera TV, Szczepankiewicz B, Vlasuk GP, Stein RL (2010) SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem 285:32695–32703

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T, Fukamizu A (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101:10042–10047

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 104:7217–7222

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dudley J, Das S, Mukherjee S, Das DK (2009) Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 20:443–452

    Article  CAS  PubMed  Google Scholar 

  • Ferrara N, Rinaldi B, Corbi G, Conti V, Stiuso P, Boccuti S, Rengo G, Rossi F, Filippelli A (2008) Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 11:139–150

    Article  CAS  PubMed  Google Scholar 

  • Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714

    Article  PubMed  Google Scholar 

  • Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, Sartorelli V (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14:661–673

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gao Z, Zhang J, Kheterpal I, Kennedy N, Davis RJ, Ye J (2011) Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem 286:22227–22234

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Giannakou ME, Partridge L (2004) The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14:408–412

    Article  CAS  PubMed  Google Scholar 

  • Goh KP, Sum CF (2010) Connecting the dots: molecular and epigenetic mechanisms in type 2 diabetes. Curr Diabetes Rev 6:255–265

    Article  CAS  PubMed  Google Scholar 

  • Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, Cohen RA, Zang M (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015–20026

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Houtkooper RH, Canto C, Wanders RJ, Auwerx J (2010a) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31:194–223

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Houtkooper RH, Williams RW, Auwerx J (2010b) Metabolic networks of longevity. Cell 142:9–14

    Article  CAS  PubMed  Google Scholar 

  • Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196

    Article  CAS  PubMed  Google Scholar 

  • Hsu CP, Oka S, Shao D, Hariharan N, Sadoshima J (2009) Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 105:481–491

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122:2170–2182

    Article  PubMed Central  PubMed  Google Scholar 

  • Hu Y, Liu J, Wang J, Liu Q (2011) The controversial links among calorie restriction, SIRT1, and resveratrol. Free Radic Biol Med 51:250–256

    Article  CAS  PubMed  Google Scholar 

  • Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK (2005) Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280:17038–17045

    Article  CAS  PubMed  Google Scholar 

  • Kao CL, Chen LK, Chang YL, Yung MC, Hsu CC, Chen YC, Lo WL, Chen SJ, Ku HH, Hwang SJ (2010) Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J Atheroscler Thromb 17:970–979

    Article  CAS  PubMed  Google Scholar 

  • Lan F, Cacicedo JM, Ruderman N, Ido Y (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283:27628–27635

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li H, Forstermann U (2009) Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15:3133–3145

    Article  CAS  PubMed  Google Scholar 

  • Li H, Wallerath T, Munzel T, Forstermann U (2002) Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7:149–164

    Article  CAS  PubMed  Google Scholar 

  • Li H, Xia N, Forstermann U (2012) Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26:102–110

    Article  PubMed  Google Scholar 

  • Li L, Zhao L, Yi-Ming W, Yu YS, Xia CY, Duan JL, Su DF (2009) Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy. Can J Physiol Pharmacol 87:56–62

    Article  PubMed  Google Scholar 

  • Liang F, Kume S, Koya D (2009) SIRT1 and insulin resistance. Nat Rev Endocrinol 5:367–373

    Article  CAS  PubMed  Google Scholar 

  • Luo X, Kraus WL (2011) A one and a two … expanding roles for poly(ADP-ribose) polymerases in metabolism. Cell Metab 13:353–355

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104:14855–14860

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mukherjee S, Lekli I, Gurusamy N, Bertelli AA, Das DK (2009) Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med 46:573–578

    Article  CAS  PubMed  Google Scholar 

  • Nadtochiy SM, Redman E, Rahman I, Brookes PS (2011) Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res 89:643–649

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, Yankner BA, Scully R, Prolla TA, Alt FW, Sinclair DA (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135:907–918

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285:8340–8351

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421–433

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Passariello CL, Zini M, Nassi PA, Pignatti C, Stefanelli C (2011) Upregulation of SIRT1 deacetylase in phenylephrine-treated cardiomyoblasts. Biochem Biophys Res Commun 407:512–516

    Article  CAS  PubMed  Google Scholar 

  • Petrovski G, Gurusamy N, Das DK (2011) Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 1215:22–33

    Article  PubMed  Google Scholar 

  • Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133–3144

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I (2008) SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:861–870

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y (2010) AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298:E751–E760

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, Li H (2009) Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60(Suppl 4):111–116

    PubMed  Google Scholar 

  • Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M (2010) Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 298:H833–H843

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307–319

    Article  CAS  PubMed  Google Scholar 

  • Sundaresan NR, Pillai VB, Gupta MP (2011) Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. J Mol Cell Cardiol 51:614–618

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, Horio Y (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375–8382

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282:6823–6832

    Article  CAS  PubMed  Google Scholar 

  • Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59:554–563

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, Zhang C, Pacher P, Csiszar A (2009) Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297:H1876–H1881

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A, Csiszar A (2007) Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292:H2417–H2424

    Article  CAS  PubMed  Google Scholar 

  • Vahtola E, Louhelainen M, Merasto S, Martonen E, Penttinen S, Aahos I, Kyto V, Virtanen I, Mervaala E (2008) Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. J Hypertens 26:334–344

    Article  CAS  PubMed  Google Scholar 

  • Wang T, Zhang X, Bheda P, Revollo JR, Imai S, Wolberger C (2006) Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol 13:661–662

    Article  CAS  PubMed  Google Scholar 

  • Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hubschle T, Mang C, Strobel H, Suzuki T, Kleinert H, Forstermann U, Ruetten H, Li H (2008) Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 325:370–379

    Article  CAS  PubMed  Google Scholar 

  • Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Munzel T, Forstermann U, Li H (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335:149–154

    Article  CAS  PubMed  Google Scholar 

  • Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yuan Q, Chen L, Xiang DX, Li YJ, Hu CP (2011) Effect of resveratrol derivative BTM-0512 on high glucose-induced dysfunction of endothelial cells: role of SIRT1. Can J Physiol Pharmacol 89:713–722

    Article  CAS  PubMed  Google Scholar 

  • Zee RS, Yoo CB, Pimentel DR, Perlman DH, Burgoyne JR, Hou X, McComb ME, Costello CE, Cohen RA, Bachschmid MM (2010) Redox regulation of sirtuin-1 by S-glutathiolation. Antioxid Redox Signal 13:1023–1032

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP, Liang CC (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80:191–199

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zhang T, Kraus WL (2010) SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 1804:1666–1675

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zheng J, Ramirez VD (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 130:1115–1123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University Medical Center, Johannes Gutenberg University, Mainz, Germany

    Huige Li

Authors
  1. Huige Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Huige Li .

Editor information

Editors and Affiliations

  1. Department of Pharmacology and Therapeutics, University of British Colombia, Vancouver, British Columbia, Canada

    Ismail Laher

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Li, H. (2014). Sirtuin 1 (SIRT1) and Oxidative Stress. In: Laher, I. (eds) Systems Biology of Free Radicals and Antioxidants. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30018-9_17

Download citation

Publish with us

Policies and ethics

Search

Navigation